Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rutherford

Showing results (561-570 of 603) with videos related to

Pageof 61
Sort By:
Acta Neuropathologica|August 8, 2013
Progressive amnestic dementia, hippocampal sclerosis, and mutation in C9ORF72Melissa E Murray, Kevin F Bieniek, M Banks Greenberg, et al.
Microbial Cell Factories|June 15, 2012
Manipulation of the carbon storage regulator system for metabolite remodeling and biofuel production in Escherichia coliAdrienne E McKee, Becky J Rutherford, Dylan C Chivian, et al.
International Journal of Radiation Oncology, Biology, Physics|January 9, 1998
Effective treatment of stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapyB C Turner, J P Knisely, B M Kacinski, et al.
Cancer Epidemiology|December 26, 2021
A way to explore the existence of "immortals" in cancer registry data - An illustration using data from ICBP SURVMARK-2Therese M-L Andersson, Mark J Rutherford, Tor Åge Myklebust, et al.
BMC Cancer|July 6, 2010
Clostridium perfringens enterotoxin carboxy-terminal fragment is a novel tumor-homing peptide for human ovarian cancerEmiliano Cocco, Francesca Casagrande, Stefania Bellone, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|February 12, 2015
Dacomitinib (PF-00299804), a second-generation irreversible pan-erbB receptor tyrosine kinase inhibitor, demonstrates remarkable activity against HER2-amplified uterine serous endometrial cancer in vitroLiancheng Zhu, Salvatore Lopez, Stefania Bellone, et al.
Circulation. Cardiovascular Quality and Outcomes|June 20, 2023
Impact of a Prior Cancer Diagnosis on Quality of Care and Survival Following Acute Myocardial Infarction: Retrospective Population-Based Cohort Study in EnglandLucy Teece, Michael J Sweeting, Marlous Hall, et al.
Parkinsonism & Related Disorders|October 23, 2012
Analysis of the C9orf72 repeat in Parkinson's disease, essential tremor and restless legs syndromeMariely Dejesus-Hernandez, Sruti Rayaprolu, Alexandra I Soto-Ortolaza, et al.
JACC. Cardiooncology|April 9, 2025
Fluoropyrimidine Chemotherapy and the Risk of Death and Cardiovascular Events in Patients With Gastrointestinal CancerAderonke T Abiodun, Chengsheng Ju, Catherine A Welch, et al.
European Heart Journal. Acute Cardiovascular Care|March 8, 2023
Acute heart failure presentation, management, and outcomes in cancer patients: a national longitudinal studyBriana Coles, Catherine A Welch, Rishabh S Motiwale, et al.
Pageof 61

Showing results (561-570 of 603) with videos related to

Sort By:
Pageof 61
Acta Neuropathologica|August 8, 2013
Progressive amnestic dementia, hippocampal sclerosis, and mutation in C9ORF72Melissa E Murray, Kevin F Bieniek, M Banks Greenberg, et al.
Microbial Cell Factories|June 15, 2012
Manipulation of the carbon storage regulator system for metabolite remodeling and biofuel production in Escherichia coliAdrienne E McKee, Becky J Rutherford, Dylan C Chivian, et al.
International Journal of Radiation Oncology, Biology, Physics|January 9, 1998
Effective treatment of stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapyB C Turner, J P Knisely, B M Kacinski, et al.
Cancer Epidemiology|December 26, 2021
A way to explore the existence of "immortals" in cancer registry data - An illustration using data from ICBP SURVMARK-2Therese M-L Andersson, Mark J Rutherford, Tor Åge Myklebust, et al.
BMC Cancer|July 6, 2010
Clostridium perfringens enterotoxin carboxy-terminal fragment is a novel tumor-homing peptide for human ovarian cancerEmiliano Cocco, Francesca Casagrande, Stefania Bellone, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|February 12, 2015
Dacomitinib (PF-00299804), a second-generation irreversible pan-erbB receptor tyrosine kinase inhibitor, demonstrates remarkable activity against HER2-amplified uterine serous endometrial cancer in vitroLiancheng Zhu, Salvatore Lopez, Stefania Bellone, et al.
Circulation. Cardiovascular Quality and Outcomes|June 20, 2023
Impact of a Prior Cancer Diagnosis on Quality of Care and Survival Following Acute Myocardial Infarction: Retrospective Population-Based Cohort Study in EnglandLucy Teece, Michael J Sweeting, Marlous Hall, et al.
Parkinsonism & Related Disorders|October 23, 2012
Analysis of the C9orf72 repeat in Parkinson's disease, essential tremor and restless legs syndromeMariely Dejesus-Hernandez, Sruti Rayaprolu, Alexandra I Soto-Ortolaza, et al.
JACC. Cardiooncology|April 9, 2025
Fluoropyrimidine Chemotherapy and the Risk of Death and Cardiovascular Events in Patients With Gastrointestinal CancerAderonke T Abiodun, Chengsheng Ju, Catherine A Welch, et al.
European Heart Journal. Acute Cardiovascular Care|March 8, 2023
Acute heart failure presentation, management, and outcomes in cancer patients: a national longitudinal studyBriana Coles, Catherine A Welch, Rishabh S Motiwale, et al.
Pageof 61